EnteroMedics (RSLS) Upgraded to Hold at ValuEngine

ValuEngine upgraded shares of EnteroMedics (NASDAQ:RSLS) from a sell rating to a hold rating in a research note published on Friday.

Separately, Zacks Investment Research cut shares of EnteroMedics from a buy rating to a hold rating in a research report on Wednesday, November 22nd.

EnteroMedics (NASDAQ:RSLS) traded up $0.04 during trading on Friday, reaching $1.40. 480,300 shares of the company’s stock traded hands, compared to its average volume of 1,609,779. EnteroMedics has a 12 month low of $1.23 and a 12 month high of $30.41.

EnteroMedics (NASDAQ:RSLS) last released its quarterly earnings data on Tuesday, November 14th. The medical device company reported ($1.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.77). The company had revenue of $0.36 million during the quarter. EnteroMedics had a negative net margin of 4,509.61% and a negative return on equity of 104.23%. equities research analysts anticipate that EnteroMedics will post -1.97 earnings per share for the current year.

WARNING: This article was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.com-unik.info/2017/12/05/enteromedics-rsls-upgraded-to-hold-at-valuengine.html.

EnteroMedics Company Profile

ReShape Lifesciences Inc, formerly EnteroMedics Inc, is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve.

To view ValuEngine’s full report, visit ValuEngine’s official website.

What are top analysts saying about EnteroMedics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for EnteroMedics Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit